Skip To Main Content
Ali Ozes on Muck Rack

Ali Ozes

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Ali Ozes’s profile

Articles by Ali Ozes

EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells

|
By Xingyue Zong, Weini Wang, Ali Ozes, Fang Fang
| cancerres.aacrjournals.org
Molecular Cell Biology Xingyue Zong, Weini Wang, Ali Ozes, Fang Fang, George E. Sandusky and Kenneth P. Nephew DOI: 10.1158/0008-5472.CAN-20-0458 Published October 2020 This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below. Abstract The majority of women diagnosed with epithelial ovarian cancer eventually develop recurrence, which rapidly evolves into chemoresistant disease.
Open in Who Shared Issue with article?

EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells

|
By Xingyue Zong, Weini Wang, Ali Ozes, Fang Fang
| cancerres.aacrjournals.org
Molecular Cell Biology Xingyue Zong, Weini Wang, Ali Ozes, Fang Fang, George E. Sandusky and Kenneth P. Nephew DOI: 10.1158/0008-5472.CAN-20-0458 Abstract The majority of women diagnosed with epithelial ovarian cancer eventually develop recurrence, which rapidly evolves into chemoresistant disease. Persistence of ovarian cancer stem cells (OCSC) at the end of therapy may be responsible for emergence of resistant tumors.
Open in Who Shared Issue with article?

EZH2-mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells

|
By Fang Fang, Xingyue Zong, Weini Wang, Ali Ozes
| cancerres.aacrjournals.org
Research Article Xingyue Zong, Weini Wang, Ali Ozes, Fang Fang, George E. Sandusky and Kenneth P. Nephew DOI: 10.1158/0008-5472.CAN-20-0458 Abstract The majority of women diagnosed with epithelial ovarian cancer (OC) eventually develop recurrence which rapidly evolves into chemoresistant disease. Persistence of ovarian cancer stem cells (OCSC) at the end of therapy may be responsible for emergence of resistant tumors.
Open in Who Shared Issue with article?
Show More